TNFRSF11B computational development network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients

Journal of Inflammation

Volumn 7, Issue , 2010, Pages

  Huang, Ju X ^a   Wang, L ^a   Jiang, Ming H ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BONE MARROW CELL ANTIGEN 2; CRANIOFACIAL DEVELOPMENT PROTEIN 1; DIACYLGLYCEROL KINASE GAMMA; GROWTH ARREST SPECIFIC PROTEIN 1; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; OSTEOPROTEGERIN; PHOSPHOTRANSFERASE; PROGRAMMED CELL DEATH 4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX6; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL ZINC FINGER PROTEIN 1; ZINC FINGER PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MOTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DATA MINING; FRONTAL CORTEX; GENETIC DATABASE; HIV ENCEPHALITIS; HUMAN; INFLAMMATION; MATHEMATICAL ANALYSIS; REGULATORY MECHANISM; RNA BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS ENCEPHALITIS; ZINC FINGER MOTIF;

EID: 77957200673     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-7-50     Document Type: Article

References (46)

1. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. E Masliah ES Roberts D Langford I Everall L Crews A Adame E Rockenstein HS Fox, J Neuroimmunol 2004 157 163 175 10.1016/j.jneuroim.2004.08. 026 15579294
2. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. L Chang GJ Wang ND Volkow T Ernst F Telang J Logan JS Fowler, Neuroimage 2008 42 869 878 10.1016/j.neuroimage. 2008.05.011 18579413
3. Magnetic resonance imaging and spectroscopy of the brain in HIV disease. M Descamps H Hyare J Stebbing A Winston, J HIV Ther 2008 13 55 58 19039299
4. Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism. MF Georgiou A Gonenc D Waldrop-Valverde RA Kuker SH Ezuddin GN Sfakianakis M Kumar, J Nucl Med 2008 49 1999 2005 10.2967/jnumed.108.052688 18997046
5. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. G Beyens A Daroszewska F de Freitas E Fransen F Vanhoenacker L Verbruggen HG Zmierczak R Westhovens J Van Offel SH Ralston, et al. J Bone Miner Res 2007 22 1062 1071 10.1359/jbmr.070333 17388729
6. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. B Chong M Hegde M Fawkner S Simonet H Cassinelli M Coker J Kanis J Seidel C Tau B Tuysuz, et al. J Bone Miner Res 2003 18 2095 2104 10.1359/jbmr.2003.18.12.2095 14672344
7. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. T Cundy M Hegde D Naot B Chong A King R Wallace J Mulley DR Love J Seidel M Fawkner, et al. Hum Mol Genet 2002 11 2119 2127 10.1093/hmg/11.18.2119 12189164
8. An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation. K Janssens MC de Vernejoul F de Freitas F Vanhoenacker W Van Hul, Bone 2005 36 542 548 10.1016/j.bone.2004.12.004 15777670
9. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. C Vidal M Brincat A Xuereb Anastasi, Maturitas 2006 53 386 395 10.1016/j.maturitas.2005.11.003 16343827
10. Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "Balkan" mutation (966-969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels. MP Whyte PN Singhellakis MB Petersen M Davies WG Totty S Mumm, J Bone Miner Res 2007 22 938 946 10.1359/jbmr.070307 17352649
11. A direct approach to false discovery rates. JD Storey., J Roy Stat Soc, Ser B 2002 64 479 498 10.1111/1467-9868.00346
12. Inferring gene regulatory networks from multiple microarray datasets. Y Wang T Joshi XS Zhang D Xu L Chen, Bioinformatics 2006 22 2413 2420 10.1093/bioinformatics/btl396 16864593
13. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. W Huang da BT Sherman Q Tan JR Collins WG Alvord J Roayaei R Stephens MW Baseler HC Lane RA Lempicki, Genome Biol 2007 8 183 10.1186/gb-2007-8-9-r183 17784955
14. DAVID: Database for Annotation, Visualization, and Integrated Discovery. G Dennis Jr BT Sherman DA Hosack J Yang W Gao HC Lane RA Lempicki, Genome Biol 2003 4 3 10.1186/gb-2003-4-5-p3 12734009
15. Secreted Phosphoprotein 1 Upstream Invasive Network Construction and Analysis of Lung Adenocarcinoma Compared with Human Normal Adjacent Tissues by Integrative Biocomputation. Y Sun L Wang M Jiang J Huang Z Liu S Wolfl, Cell Biochem Biophys 2009 ISSN: 1085-9195 (Print) 1559-0283 (Online) 19756411
16. Integrative decomposition procedure and Kappa statistics set up ATF2 ion binding module in Malignant Pleural Mesothelioma (MPM). Y Sun L Wang L Lui, Frontiers of Electrical and Electronic Engineering in China 2008 3 381 387 10.1007/s11460-008-0086-3
17. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues. L Wang J Huang M Jiang X Zheng, Tumour Biol
18. FOS proliferating network construction in early colorectal cancer (CRC) based on integrative significant function cluster and inferring analysis. L Wang Y Sun M Jiang S Zhang S Wolfl, Cancer Invest 2009 27 816 824 10.1080/07357900802672753 19557575
19. Integrative decomposition procedure and Kappa statistics for the distinguished single molecular network construction and analysis. L Wang Y Sun M Jiang X Zheng, J Biomed Biotechnol 2009 726728 19390583
20. Developmental and daily expression of the Pax4 and Pax6 homeobox genes in the rat retina: localization of Pax4 in photoreceptor cells. MF Rath MJ Bailey JS Kim SL Coon DC Klein M Moller, J Neurochem 2008 19012751
21. Expression patterns of Shh, Ptc2, Raldh3, Pitx2, Isl1, Lim3 and Pax6 in the developing chick hypophyseal placode and Rathke's pouch. M Sjodal L Gunhaga, Gene Expr Patterns 2008 8 481 485 10.1016/j.gep.2008.06.007 18647663
22. A Sox1 to Pax6 switch drives neuroectoderm to radial glia progression during differentiation of mouse embryonic stem cells. DM Suter D Tirefort S Julien KH Krause, Stem Cells 2008 18032703
23. Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system. TC Tuoc A Stoykova, Genes Dev 2008 22 1972 1986 10.1101/gad.471708 18628401
24. Molecular analysis of the PAX6 gene in Mexican patients with congenital aniridia: report of four novel mutations. CE Villarroel C Villanueva-Mendoza L Orozco MA Alcantara-Ortigoza DF Jimenez JC Ordaz A Gonzalez-del Angel, Mol Vis 2008 14 1650 1658 18776953
25. Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). JH Wen YY Chen SJ Song J Ding Y Gao QK Hu RP Feng YZ Liu GC Ren CY Zhang, et al. Diabetologia 2008 19034419
26. Diacylglycerol kinase beta accumulates on the perisynaptic site of medium spiny neurons in the striatum. Y Hozumi M Fukaya N Adachi N Saito K Otani H Kondo M Watanabe K Goto, Eur J Neurosci 2008 28 2409 2422 10.1111/j.1460-9568. 2008.06547.x 19087171
27. Diacylglycerol kinase beta promotes dendritic outgrowth and spine maturation in developing hippocampal neurons. Y Hozumi M Watanabe K Otani K Goto, BMC Neurosci 2009 10 99 10.1186/1471-2202-10-99 19691842
28. Diacylglycerol kinase zeta is involved in the process of cerebral infarction. T Nakano Y Hozumi H Ali S Saino-Saito H Kamii S Sato T Kayama M Watanabe H Kondo K Goto, Eur J Neurosci 2006 23 1427 1435 10.1111/j.1460-9568. 2006.04685.x 16553606
29. Brain trauma induces expression of diacylglycerol kinase zeta in microglia. T Nakano K Iseki Y Hozumi K Kawamae I Wakabayashi K Goto, Neurosci Lett 2009 461 110 115 10.1016/j.neulet.2009.06.001 19520144
30. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene. S Gobeil X Zhu CJ Doillon MR Green, Genes Dev 2008 22 2932 2940 10.1101/gad.1714608 18981472
31. O-mannosylation is required for degradation of the endoplasmic reticulum-associated degradation substrate Gas1*p via the ubiquitin/proteasome pathway in Saccharomyces cerevisiae. H Hirayama M Fujita T Yoko-o Y Jigami, J Biochem 2008 143 555 567 10.1093/jb/mvm249 18182384
32. Gas1 reduces Ret tyrosine 1062 phosphorylation and alters GDNF-mediated intracellular signaling. MA Lopez-Ramirez G Dominguez-Monzon P Vergara J Segovia, Int J Dev Neurosci 2008 26 497 503 10.1016/j.ijdevneu.2008.02.006 18394855
33. Gas1 is a modifier for holoprosencephaly and genetically interacts with sonic hedgehog. M Seppala MJ Depew DC Martinelli CM Fan PT Sharpe MT Cobourne, J Clin Invest 2007 117 1575 1584 10.1172/JCI32032 17525797
34. Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line. B Lankat-Buttgereit S Muller H Schmidt KG Parhofer TM Gress R Goke, Biol Cell 2008 100 703 715 10.1042/BC20080052 18549351
35. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. T Schmid AP Jansen AR Baker G Hegamyer JP Hagan NH Colburn, Cancer Res 2008 68 1254 1260 10.1158/0008-5472.CAN-07-1719 18296647
36. PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. C Suzuki RG Garces KA Edmonds S Hiller SG Hyberts A Marintchev G Wagner, Proc Natl Acad Sci USA 2008 105 3274 3279 10.1073/pnas.0712235105 18296639
37. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. F Talotta A Cimmino MR Matarazzo L Casalino G De Vita M D'Esposito R Di Lauro P Verde, Oncogene 2008 18850008
38. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Q Wang Z Sun HS Yang, Oncogene 2008 27 1527 1535 10.1038/sj.onc.1210793 17828298
39. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma. X Wang Z Wei F Gao X Zhang C Zhou F Zhu Q Wang Q Gao C Ma W Sun, et al. Anticancer Res 2008 28 2991 2996 19031945
40. CP27 function is necessary for cell survival and differentiation during tooth morphogenesis in organ culture. TG Diekwisch X Luan, Gene 2002 287 141 147 10.1016/S0378-1119(01)00868-X 11992732
41. CP27 localization in the dental lamina basement membrane and in the stellate reticulum of developing teeth. TG Diekwisch X Luan JE McIntosh, J Histochem Cytochem 2002 50 583 586 11897812
42. Gene organization of bovine BCNT that contains a portion corresponding to an endonuclease domain derived from an RTE-1 (Bov-B LINE), non-LTR retrotransposable element: duplication of an intramolecular repeat unit downstream of the truncated RTE-1. S Iwashita T Itoh H Takeda Y Sugimoto I Takahashi T Nobukuni M Sezaki T Masui K Hashimoto, Gene 2001 268 59 66 10.1016/S0378-1119(01)00422-X 11368901
43. A transposable element-mediated gene divergence that directly produces a novel type bovine Bcnt protein including the endonuclease domain of RTE-1. S Iwashita N Osada T Itoh M Sezaki K Oshima E Hashimoto Y Kitagawa-Arita I Takahashi T Masui K Hashimoto W Makalowski, Mol Biol Evol 2003 20 1556 1563 10.1093/molbev/msg168 12832649
44. CP27 affects viability, proliferation, attachment and gene expression in embryonic fibroblasts. X Luan TG Diekwisch, Cell Prolif 2002 35 207 219 10.1046/j.1365-2184.2002.00238.x 12153613
45. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. AS Lanzrein CM Johnston VH Perry KA Jobst EM King AD Smith, Alzheimer Dis Assoc Disord 1998 12 215 227 10.1097/00002093-199809000-00016 9772027
46. Tumor necrosis factor receptor-II: heritability and effect on brain morphology in schizophrenia. TH Wassink RR Crowe NC Andreasen, Mol Psychiatry 2000 5 678 682 10.1038/sj.mp.4000807 11126399